Cargando…
CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
BACKGROUND: CD133 is a marker of stem cells as well cancer stem cells. This study investigated the association between CD133 expression in cancer cells and the clinical outcome of non-mucin producing intrahepatic cholangiocarcinoma (ICC). METHODS: Fifty-seven non-mucin producing ICC patients were en...
Autores principales: | Cai, Xiaobo, Li, Jun, Yuan, Xiaodong, Xiao, Jingbo, Dooley, Steven, Wan, Xinjian, Weng, Honglei, Lu, Lungen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838940/ https://www.ncbi.nlm.nih.gov/pubmed/29510695 http://dx.doi.org/10.1186/s12967-018-1423-9 |
Ejemplares similares
-
Peritumoral ductular reaction can be a prognostic factor for intrahepatic cholangiocarcinoma
por: Shen, Zhenyang, et al.
Publicado: (2020) -
High level of CD73 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Xu, Ya-ping, et al.
Publicado: (2021) -
Autophagy Plays a Role in the CUL4A-Related Poor Prognosis of Intrahepatic Cholangiocarcinoma
por: Weng, Shao-Wen, et al.
Publicado: (2021) -
SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018) -
Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018)